Srikanth Elesela

Experience

• 

  K.C.P.SUGAR AND INDUSTRIES CORPORATION LIMITED

  Dec 2003 - Nov 2004

  R&D Trainee

  # Identification, development and maintenance of Microbial cultures for Agricultural farms and Aqua culture farms

• 

  Council of Scientific and Industrial Research

  Apr 2011 - Apr 2012

  Senior Research Fellow

  # Molecular Cloning of filarial cysteine protease

• 

  TRANSLATIONAL HEALTH SCIENCE AND TECHNOLOGY INSTITUTE

  Dec 2012 - Dec 2014

  Postdoctoral Fellow

  # Established the essential role of Foxo1 in the induction of Interleukin-9 (IL-9) in T helper cells (Nat Comm, 2017).# Mentored 2 Graduate students.

• 

  Purdue University

  Feb 2015 - Dec 2016

  Postdoctoral Research Associate

  # Evaluated the role of type 2 Innate lymphoid cells (ILC2) in a SHARPIN-deficient mouse model.# Optimized a method for Flow cytometric analysis of transportation of nano particles (Nano-11) by antigen presenting cells to the draining lymph nodes (Npj Vaccines, 2017).

• 

  University of Michigan Medical School

  Jan 2017 - May 2022

  Postdoctoral Research Fellow

  # Demonstrated the therapeutic potential of mucosal IgA immune complex for allergic airway and intestinal Th2 disease (JACI, Aug’2023).# Established a critical role of Sirtuin 1 in immune homeostasis during Respiratory syncytial virus (RSV) pathogenesis. (PLOS Pathogens, Feb’2020).# Filed US Patent for a method development (IgA-immune complex) to study Allergic diseases (2022, University of Michigan).

• 

  Ring Therapeutics

  May 2022 - Apr 2024

  Senior Scientist

  # Designed and developed key immunogenicity assays to Anelloviral vectors and progressed the discovery of novel targets across multiple disease models.# Served as CAR-T program subject matter expert.# Managed and developed a team of young scientists: 2 direct reports# Managed Flow Cytometry facility: Trained scientists and Research Associates